Anna Eglseer
Overview
Explore the profile of Anna Eglseer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
1
Citations
0
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elmer D, Stockmaier G, Grund-Groschke S, Strobl V, Dang H, Wiederstein M, et al.
Cell Commun Signal
. 2025 Feb;
23(1):91.
PMID: 39962447
Background: Pharmacological targeting of Hedgehog (HH)/GLI has proven effective for certain blood, brain and skin cancers including basal cell carcinoma (BCC). However, limited response rates and the development of drug...
2.
Sieberer H, Luciano M, Amend D, Blochl C, Eglseer A, Steinkellner A, et al.
Cell Commun Signal
. 2025 Jan;
23(1):53.
PMID: 39875995
FLT3 mutations occur in approximately 25% of all acute myeloid leukemia (AML) patients. While several FLT3 inhibitors have received FDA approval, their use is currently limited to combination therapies with...
3.
Luciano M, Sieberer H, Krenn P, Dang H, Vetter J, Neuper T, et al.
Cell Commun Signal
. 2024 Sep;
22(1):424.
PMID: 39223663
Background: Acute myeloid leukemia (AML) is characterized by the abnormal proliferation of myeloid precursor cells and presents significant challenges in treatment due to its heterogeneity. Recently, the NLRP3 inflammasome has...